NO173635C - Fremgangsmaate for fremstilling av en stabil injiserbar opploesning av et antrakinonderivat - Google Patents

Fremgangsmaate for fremstilling av en stabil injiserbar opploesning av et antrakinonderivat

Info

Publication number
NO173635C
NO173635C NO870950A NO870950A NO173635C NO 173635 C NO173635 C NO 173635C NO 870950 A NO870950 A NO 870950A NO 870950 A NO870950 A NO 870950A NO 173635 C NO173635 C NO 173635C
Authority
NO
Norway
Prior art keywords
anthracinone
derivative
preparing
procedure
injectable solution
Prior art date
Application number
NO870950A
Other languages
English (en)
Norwegian (no)
Other versions
NO870950D0 (no
NO870950L (no
NO173635B (no
Inventor
Pradeep V Niphadkar
Narenda R Desai
Paul N Jones
Kieran G Mooney
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO870950D0 publication Critical patent/NO870950D0/no
Publication of NO870950L publication Critical patent/NO870950L/no
Publication of NO173635B publication Critical patent/NO173635B/no
Publication of NO173635C publication Critical patent/NO173635C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
NO870950A 1986-03-07 1987-03-06 Fremgangsmaate for fremstilling av en stabil injiserbar opploesning av et antrakinonderivat NO173635C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83724386A 1986-03-07 1986-03-07

Publications (4)

Publication Number Publication Date
NO870950D0 NO870950D0 (no) 1987-03-06
NO870950L NO870950L (no) 1987-09-08
NO173635B NO173635B (no) 1993-10-04
NO173635C true NO173635C (no) 1994-01-12

Family

ID=25273922

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870950A NO173635C (no) 1986-03-07 1987-03-06 Fremgangsmaate for fremstilling av en stabil injiserbar opploesning av et antrakinonderivat

Country Status (21)

Country Link
EP (1) EP0236822B1 (de)
JP (1) JPH0717500B2 (de)
KR (1) KR900002030B1 (de)
AT (1) ATE59290T1 (de)
AU (1) AU593330B2 (de)
CA (1) CA1283607C (de)
DE (1) DE3766984D1 (de)
DK (1) DK166754B1 (de)
ES (1) ES2033247T3 (de)
FI (1) FI84977C (de)
GR (1) GR3001503T3 (de)
HK (1) HK63991A (de)
HU (1) HU199286B (de)
IE (1) IE60025B1 (de)
IL (1) IL81681A (de)
NO (1) NO173635C (de)
NZ (1) NZ219454A (de)
PH (1) PH22808A (de)
PT (1) PT84398B (de)
SG (1) SG45292G (de)
ZA (1) ZA871652B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0705601B1 (de) * 1994-10-04 2000-01-19 LOMAPHARM Rudolf Lohmann GmbH KG Pharmazeutische Fabrik Lösungen von Anthrachinonen zur parenteralen Applikation
DE19818802A1 (de) * 1998-04-27 1999-10-28 Dresden Arzneimittel Stabile Mitoxantron-Lösungen
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
CN103260616B (zh) * 2010-12-09 2015-09-09 丸石制药株式会社 对乙酰氨基酚的稳定化剂
CN114601791B (zh) * 2020-12-08 2023-09-19 成都倍特药业股份有限公司 一种盐酸米托蒽醌液体制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3230143A (en) * 1965-05-14 1966-01-18 Merck & Co Inc Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
US4328213A (en) * 1979-11-28 1982-05-04 Schering Corporation Stable injectable labetalol formulation
ATE48942T1 (de) * 1984-02-27 1990-01-15 American Cyanamid Co Verwendung von 1,4 bisubstituierten anthrachinonen zur herstellung von immunsuppressiva.

Also Published As

Publication number Publication date
GR3001503T3 (en) 1992-11-23
KR900002030B1 (ko) 1990-03-31
NZ219454A (en) 1989-04-26
EP0236822A2 (de) 1987-09-16
AU593330B2 (en) 1990-02-08
PH22808A (en) 1988-12-27
FI84977C (fi) 1992-02-25
AU6977387A (en) 1987-09-10
EP0236822A3 (en) 1989-01-11
JPH0717500B2 (ja) 1995-03-01
IL81681A0 (en) 1987-09-16
DE3766984D1 (de) 1991-02-07
CA1283607C (en) 1991-04-30
PT84398B (pt) 1989-10-04
EP0236822B1 (de) 1990-12-27
NO870950D0 (no) 1987-03-06
NO870950L (no) 1987-09-08
PT84398A (en) 1987-04-01
ES2033247T3 (es) 1993-03-16
ATE59290T1 (de) 1991-01-15
IE60025B1 (en) 1994-05-18
KR870008581A (ko) 1987-10-19
FI870994L (fi) 1987-09-08
HUT47020A (en) 1989-01-30
SG45292G (en) 1992-06-12
DK116687D0 (da) 1987-03-06
DK116687A (da) 1987-09-08
DK166754B1 (da) 1993-07-12
HU199286B (en) 1990-02-28
HK63991A (en) 1991-08-23
IL81681A (en) 1991-01-31
JPS62265220A (ja) 1987-11-18
FI84977B (fi) 1991-11-15
ZA871652B (en) 1987-08-28
NO173635B (no) 1993-10-04
IE870569L (en) 1987-09-07
FI870994A0 (fi) 1987-03-06

Similar Documents

Publication Publication Date Title
FI871913A0 (fi) Menetelmä oraalisen, farmaseuttisen valmisteen valmistamiseksi, joka on pysyvä värin muuttumista vastaan
ES2115589T3 (es) Medicamento que contiene acido r-alfa-liponico o acido s-alfa-liponico como sustancia activa.
NO883054D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat inneholdende somatostatinanaloger.
DK644388D0 (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
FR2695387B1 (fr) Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ES523653A0 (es) Procedimiento de obtencion de composiciones farmaceuticas a base de derivados de acido glicirretinico.
NO169843C (no) Analogifremgangsmaate for fremstilling av visse 2-substituerte adenosinderivater
NO862587L (no) Fremgangsmaate for fremstilling av en injiserbar opploesning inneholdende et antitumorantracyklinglykosid.
DK583188D0 (da) Farmaceutiske praeparater indeholdende ergolin-derivatet pergolid og fremgangsmaade til stabilisering af saadanne praeparater
NO173635C (no) Fremgangsmaate for fremstilling av en stabil injiserbar opploesning av et antrakinonderivat
SE8704097D0 (sv) Oral formulation of buspirone and salts thereof
PT88681A (pt) A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives
PT87564A (pt) Process for preparing substituted vinylcephalosporins useful as medicaments
DK259486D0 (da) Fremgangsmaade til fremstilling af 7-aca-derivater
NO812593L (no) Fremgangsmaate for optisk opploesning av blandinger av d- og 1-propionsyre-derivater
ES2061481T3 (es) Derivados de 3,4-dihidrobenzoazina opticamente activos y procedimiento para la preparacion de los mismos.
ATE57913T1 (de) Catechinamide, verfahren zu ihrer herstellung, zwischenprodukte und pharmazeutische zubereitung.
NO870233D0 (no) Fremgangsmaate for fremstilling av stabile tiolesterderivater.
NO882224L (no) Fremgangsmaate for fremstilling av analoger av alfa-msh.
ATE75613T1 (de) 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen.
NO881256D0 (no) Fremgangsmaate for fremstilling av 5-hydroksydiprafenon og syreaddisjonssalter derav.
NO155428C (no) Fremgangsmaate for fremstilling av en stabil loesning av hydrogenerte ergotalkaloider.
ES548146A0 (es) Procedimiento de preparacion de un derivado del acido aceti-co
ES549788A0 (es) Procedimiento de preparacion de derivados de 4-(bis(4-fluo- rofenil)metilen)-piperidina